Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,663 | -27,152 | -13,659 | -9,129 | -27,781 |
| Depreciation Amortization | 1,564 | 1,001 | 661 | 335 | 1,680 |
| Accounts receivable | -1,129 | 275 | 399 | 323 | 109 |
| Accounts payable and accrued liabilities | 967 | 263 | -386 | 854 | -4,757 |
| Other Working Capital | -1,293 | -170 | -160 | 1,019 | -3,971 |
| Other Operating Activity | 39,865 | 10,445 | 3,337 | 2,768 | 11,395 |
| Operating Cash Flow | $-20,689 | $-15,338 | $-9,808 | $-3,830 | $-23,325 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 367 |
| PPE Investments | -512 | -302 | -215 | -24 | 73 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,372 |
| Investing Cash Flow | $-512 | $-302 | $-215 | $-24 | $-932 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -201 | -119 | -33 | N/A | -117 |
| Common Stock Issued | 26,440 | 15,825 | 15,807 | N/A | 13,848 |
| Other Financing Activity | -5,810 | -6,114 | -5,927 | 0 | -1,545 |
| Financing Cash Flow | $20,429 | $9,592 | $9,847 | $N/A | $12,186 |
| Exchange Rate Effect | -24 | -21 | N/A | N/A | N/A |
| Beginning Cash Position | 11,132 | 11,132 | 11,132 | 11,132 | 23,203 |
| End Cash Position | 10,336 | 5,063 | 10,956 | 7,278 | 11,132 |
| Net Cash Flow | $-796 | $-6,069 | $-176 | $-3,854 | $-12,071 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,689 | -15,338 | -9,808 | -3,830 | -23,325 |
| Capital Expenditure | -516 | -302 | -215 | -24 | -281 |
| Free Cash Flow | -21,205 | -15,640 | -10,023 | -3,854 | -23,606 |